XVI Years of Dedicated FDA & USDA Regulatory Advocacy

When we opened our doors, the regulatory frameworks governing food, drugs, medical devices, cosmetics, and tobacco were vastly different than they are today. Over the past decade and a half, we have guided domestic and international companies through sweeping paradigm shifts—from the rollout of the Food Safety Modernization Act (FSMA) to the recent implementation of the Quality Management System Regulation (QMSR) for medical devices and the sweeping oversight changes brought by MoCRA in the cosmetics sector.

Our longevity is a testament to a singular commitment: providing sophisticated, business-minded legal counsel strictly within our core competencies.

A Practice Built on Continuous Readiness and Deep Substantive Expertise

Regulatory compliance is not a static checkbox. It is a moving target. Over 16 years of focused advocacy, our firm has developed a reputation for helping clients anticipate regulatory trends before they impact operations. Our experience spans the full lifecycle of regulated products:

• Strategic Market Entry & Approvals: Counseling developers through rigorous premarket pathways, including complex 510(k) submissions for medical devices, digital health applications, and navigating the exacting demands of Premarket Tobacco Product Applications (PMTAs).

• Crisis Management & Enforcement Defense: Representing manufacturers, importers, and national distributors caught in the crosshairs of aggressive federal oversight. We routinely manage the critical, high-stakes windows following adverse inspectional findings, successfully drafting comprehensive CAPA responses to Form FDA 483s, contesting Warning Letters, and managing recalls to protect client supply chains.

• Global Supply Chain Governance: Advising international entities attempting to navigate the complex entry requirements of the U.S. market, serving as an authoritative U.S. Agent, and restructuring Quality Agreements to properly allocate risk between brands and contract manufacturers.

Looking Ahead: The Next Era of Administrative Law

As we look toward the future, the integration of artificial intelligence in regulatory screening, data-driven enforcement models, and shifting administrative dynamics will present unprecedented challenges to life sciences and consumer goods companies.

Whether advising an emerging digital health platform engineering boundaries for an AI wellness application, or a legacy cosmetics brand structuring its safety substantiation data for mandatory renewals, our approach remains unchanged. We combine deep technical knowledge with a practical understanding of how federal agencies operate to deliver defensible, commercial-ready solutions.

We extend our deepest gratitude to our clients, co-counsel, and industry partners who have trusted us to protect their innovations and operations over the last 16 years. We look forward to continuing to serve as your dedicated regulatory counsel in the chapters to come.